Clinical and microbiological features of a cohort of patients with Acinetobacter baumannii bloodstream infections

Purpose Acinetobacter baumannii is emerging as a pathogen that is a focus of global concern due to the frequent occurrence of the strains those are extensively resistant to antibiotics. This study was aimed to analyze the clinical and microbiological characteristics of a cohort of patients with A. baumannii bloodstream infections (BSIs) in western China. Methods A retrospective study of the patients at West China Hospital of Sichuan University with A. baumannii BSIs between Jan, 2018 and May, 2023 was conducted. Antimicrobial susceptibility of A. baumannii isolates was tested by microdilution broth method. Whole-genome sequencing and genetic analysis were also performed for these isolates. Results Among the 117 patients included, longer intensive care unit stay, higher mortality, and more frequent invasive procedures and use of more than 3 classes of antibiotics were observed among the carbapenem-resistant A. baumannii (CRAB)-infected group (n = 76), compared to the carbapenem-susceptible A. baumannii (CSAB)-infected group (n = 41, all P ≤ 0.001). Twenty-four sequence types (STs) were determined for the 117 isolates, and 98.7% (75/76) of CRAB were identified as ST2. Compared to non-ST2 isolates, ST2 isolates exhibited higher antibiotic resistance, and carried more resistance and virulence genes (P < 0.05). In addition, 80 (68.4%) isolates were CRISPR-positive, showed higher antibiotic susceptibility, and harbored less resistance and virulence genes, in comparison to CRISPR-negative ones (P < 0.05). Phylogenetic clustering based on coregenome SNPs indicated a sporadic occurrence of clonal transmission. Conclusion Our findings demonstrate a high frequency of ST2 among A. baumannii causing BSIs, and high antibiotic susceptibility of non-ST2 and CRISPR-positive isolates. It is necessary to strengthen the surveillance of this pathogen. Supplementary Information The online version contains supplementary material available at 10.1007/s10096-024-04881-0.


Introduction
Acinetobacter baumannii has emerged as an important pathogen that causes infectious diseases such as pneumonia, bloodstream infections (BSIs), meningitis, and skin or soft tissue infections [1].In recent years, there has been a sharp decline in the in vitro susceptibility to antibiotics among worldwide isolates of A. baumannii [2].Critically, carbapenem-resistant A. baumannii (CRAB) is only susceptible to a small number of antimicrobial agents, which raises locus 1 (OCL1) [14], and genes involved in type VI secretory system (T6SS) [15], differed among A. baumannii strains causing BSIs.Also, various sequence types (STs) were identified among these isolates, and their relationship with the prognosis was variable.For example, the 30-day mortality was high in ST191, but rather low in ST451 [16].ST191/195/208 strains prevailed in the patients with severe infections, demonstrated increased multidrug antimicrobial resistance, and caused excessive mortality, compared to the other stains [17].Further research is needed to fully elucidate the clinical features of A. baumannii BSIs and to determine the antimicrobial susceptibility patterns and genotypes of the isolates, in order to guide optimal management of the patients.Therefore, the present study was aimed to identify the clinical and microbiological characteristics of a cohort of patients with A. baumannii BSIs.

Patient inclusion and data collection
A retrospective study was conducted in the West China Hospital of Sichuan University, in Chengdu, China, according to the STROBE guidelines (Strengthening the Reporting of Observational Studies in Epidemiology) [18].Medical data from patients suffering from A. baumannii BSIs between Jan 1st, 2018, and May 31st 2023 were retrieved from the hospital information system. A. baumannii BSI was defined as isolation of the bacterium from blood culture during the study period.Each case was ensured by the clinicians that the primary infection sites met the National Healthcare Safety Network (NHSN) definitions [19].At last, 117 cases were included for further analysis.According to the in vitro susceptibility of A. baumannii isolates to carbapenem, the included cases were divided into a CRAB-infected group (n = 76) and a carbapenem-susceptible A. baumannii (CSAB)-infected group (n = 41).The flowchart for the patient inclusion and exclusion is summarized in Supplementary material Figure S1.

Bacterial identification and whole-genome sequencing
A. baumannii strains isolated from the patients included were recovered on Luria-Bertani agar and incubated overnight at 37℃.The isolates were identified by a matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) Biotyper ® Sirius System (Bruker Daltonics GmbH, Bremen, Germany), and confirmed via whole genome-sequencing using an Illumina NovaSeq 6000 platform (Illumina, San Diego, CA, USA).Escherichia coli ATCC25922 and A. baumannii ATCC19606 were used as control strains.

Antimicrobial susceptibility testing (AST) of the isolates
The in vitro susceptibility of the isolates to antibiotics was determined using a Vitek 2 compact system (bioMérieux, Lyon, France) according to the manufacturer's recommendations.The results of minimum inhibitory concentration (MIC) were interpreted by the Clinical and Laboratory Standards Institute supplement M100-Ed33 [20].E. coli ATCC25922 and Pseudomonas aeruginosa ATCC27853 acted as control strains.

Statistical analysis
Continuous variables (e.g.ages, days) were expressed as the median with interquartile range (IQR), and categorical variables as frequency and percentage.The association between patients and bacterial characteristics was assessed with chisquared tests for categorical variables and t-tests or Wilcoxon tests for continuous variables.Adjusted odds ratios (aOR) and 95% confidence intervals (CIs) were obtained from a multivariable logistic regression model.Data were analyzed using SPSS 26.0 software (SPSS Inc, USA) and a two-side P < 0.05 was considered statistically significant.

Ethics declarations
Ethical permission was obtained by approval of the institutional review board of the West China Hospital of Sichuan University Clinical Trial center (No.2020 -954), in accordance with the International Guideline for Ethical Review of Epidemiological Studies and Declaration of Helsinki.The informed consent was waived because this study was a retrospective study with review of related data through the electronic medical records.

Characteristics of A. baumannii BSIs
The demographics, clinical and microbiological features of the cases in the CRAB-infected (n = 76) and CSAB-infected (n = 41) groups are summarized in Table 1.A high 7-day mortality (43.6%) was observed among the 117 patients, and the mortality of the CRAB-infected group was much higher than that of the CSAB-infected group (57.9% versus 17.1%, P< 0.001).Stay in intensive care unit (ICU), invasive procedures, and the usage of more than 3 classes of antibiotics were more common in the CRAB-infected group, compared to the CSAB-infected group (all P< 0.05).Multivariate logistic regression analysis found that stay in ICU (aOR: 5.95; 95% CI 1.84-20.04;P = 0.003), nasogastric tube placement (aOR: 6.50; 95% CI 1.44-33.78;P = 0.018), mechanical ventilation (aOR: 13.50; 95% CI 5.34-49.5;P < 0.001), and usage of more than 3 classes of antibiotics (aOR: 3.40; 95% CI 1.19-10.10;P = 0.023) were the independent risk factors for the patients with CRAB BSIs.

Antimicrobial resistance phenotype and genomic features of CRISPR-positive and CRISPR-negative A. baumannii isolates
As demonstrated in Figs. 1 and 2, 68.4% (n = 80) of the 117 isolates carried CRISPR arrays.The CRISPR-negative isolates were more resistant to the antibiotics tested, compared to CRISPR-positive ones (Table 2, all P ≤ 0.001).Also, there were larger number of genes related to antimicrobial resistance and virulence among CRISPR-negative isolates, compared to CRISPR-positive ones (Fig. 3A; Tables 3 and  4).

Phylogenetic analysis of A. baumannii isolates
The core-genome SNPs analysis of 117 A. baumannii isolates revealed an extensive genetic diversity, identifying 2 to 176,740 SNPs, 1,871 core genes that are common across all the strains, alongside a vast number of accessory (139,665) and unique (1,996) genes.Two clades, labeled as A and B in Fig. 1, were identified.The clade A included 75 ST2 (matrix distance: 2 ~ 720 SNPs), and the clade B had 42 non-ST2 ones (matrix distance: 3400 ~ 5474 SNPs).The closest genetic relationship was found among 10 ST2 CRAB and variant-deletions 26,192, and variant-complex 530,114), which highlighted the prominence of ST2.The main genetic branches of ST2 versus non-ST2 isolates, and CRISPR-positive versus CRISPR-negative ones were shown in Figure S2-S5, respectively.2 non-ST2 CSAB isolates (Figs. 1 and 4), indicating clonal transmissions might occur.
Among the 75 ST2 isolates, a broad spectrum of genetic variation was characterized, including 3,355,802 variants (variant-SNPs 2,769,376, variant-insertions 30,120, (1) A. baumannii BSI,the isolation of A. baumannii from blood culture of the cases ensured by the clinicians that the primary infection sites met the National Healthcare Safety Network (NHSN) definitions; (2) Length of stay in hospital, the number of days that patients spent in hospital from admission to discharge; (3) Stay in ICU, the admission to ICU prior to positive blood culture; (4) Invasive procedures, the administration of the nasogastric tube placement, urinary catheterization, intravascular catheterization, mechanical ventilation, or surgery one week prior to positive blood culture; (5) A. baumannii isolated from respiratory tract, the isolation of A. baumannii from respiratory tract specimens prior to positive blood culture (6) Usage of more than 3 classes of antibiotics, the administration of more than 3 classes of antibiotics prior to positive blood culture; (7) 7-day mortality, the ratio of the death during 7 days after positive blood culture    gene that encodes a class D carbapenemase and contributes to a higher level of carbapenem resistance in A. baumannii [36].The 3 isolates of bla OXA−23 -negative CRAB carried bla OXA−66, which is another kind of carbapenemase gene.The virulence factors identified in A. baumannii were mainly involved in immune modulation, biofilm formation, nutrition, metabolism, and regulation [37].The ompA gene, encoding outer membrane protein A (OmpA) [38], was detected in all the CRAB isolates.The gene bap, contributing to biofilm production, cell adhesion, and invasion [39,40], was identified in 97.4% (74/76) of CRAB isolates.The quorum sensing system abaI/abaR, as a signal transduction factor and acyl-homoserine lactone (AHL) synthase receptor [41], was detected in 93.4% (71/76) of CRAB isolates.
The CRISPR-Cas system is a form of bacterial immune protection against the invasion of mobile genetic elements [42].CRISPR-positive isolates of Klebsiella pneumoniae have been shown to be more susceptible to antibiotics compared to CRISPR-negative ones [43].In present study, CRISPR-positive A. baumannii isolates showed higher in vitro susceptiblity to antibiotics, and carried fewer resistance and virulence genes, compared to CRISPR-negative ones.This finding suggests that the CRISPR array may be a barrier to antimicrobial resistance in CSAB isolates, which might provide a new insight into the prevention and control of infections caused by this pathogen.
In our study, ST2 was identified in 64.1% of 117 A. baumannii isolates and 98.7% of 76 CRAB isolates.Other studies about A. baumannii BSIs reported that 52.0% of the isolates were identified as ST2 [44], and all the multidrugresistant isolates as ST2 [32].The dissemination of A. baumannii ST2 has attracted significant attention due to high resistance of the isolates and high mortality of the patients [44].ST2 isolates showed multidrug resistance and harbored important virulence factors [45,46].Similarily, in our study, ST2 isolates carried more resistance and virulence genes, compared to non-ST2 ones.Furthermore, 12 isolates (with ≤ 10 SNVs) were found to be closely related genetically, which indicated that clonal transmission might occur.
There were some limitations in our study.It was a retrospective study conducted in a single center, and the sample

Discussion
BSIs caused by multidrug-resistant bacteria are usually associated with the poor prognosis of the patients.In present study, a high 7-day mortality (43.6%) was observed among the patients with A. baumannii BSIs.Moreover, the mortality of CRAB-infected group was much higher than that of the CSAB-infected group (57.9% versus 17.1%).The high mortality (69.4%, 75/108) of CRAB BSIs was also observed previously [32].All of our cases in the CRAB-infected group received invasive procedures, and 92.1% of these cases were administered with more than 3 classes of antimicrobial agents.Interestingly, we observed that A. baumannii was also isolated from respiratory tract in 43.4% (33/76) of cases in the CRAB-infected group and 26.8% (11/41) of cases in the CSAB-infected group.These data may be due to the colonization of A. baumannii in the respiratory tract as a crucial step that precedes the development of BSIs [33].
Recently, the increasing resistance of A. baumannii to antimicrobial agents has emerged as a global health concern.According to the China Antimicrobial Surveillance Network report (http://www.chinets.com),the resistance of A. baumannii to imipenem increased from 32.9% in 2005 to 71.2% in 2022.In our study, all of the CRAB isolates were resistant to multiple classes of antibiotics.The infections in other sites (e.g.respiratory tract) and variable comorbidities (as described in Table 1) might contribute to the high mortality among our CRAB-infected group, despite 68.4% of them were administrated with last-line antibiotics such as tigecycline and colistin.Similarly, the previous studies found that although tigecycline and colistin had not significantly reduced the death of patients with CRAB associated infections for prominent toxicity (both nephrotoxicity and neurotoxicity) and low plasma concentrations of the colistin contributing to failed treatments [34,35].Therefore, the prevention of CRAB BSIs may be critically important under such circumstances.
Furthermore, we identified the resistance phenotypes and associated genes of the isolates in this study.We found that 96.1% (73/76) of the CRAB isolates carried bla OXA−23 , a size was small.Further research is needed to enlarge the sample size to find more genetic relationship among the A. baumannii isolates causing BSIs.
In conclusion, stay in ICU, nasogastric tube placement, mechanical ventilation, and usage of more than 3 classes of antibiotics were found to be the risk factors for CRAB BSIs.ST2 isolates exhibited higher antibiotic resistance, and carried more resistance and virulence genes, in comparison to non-ST2 ones.CRISPR-negative isolates were more resistant to antibiotics, and harbored more resistance and virulence genes, compared to CRISPR-positive ones.Phylogenetic clustering based on core-genome SNPs indicated a sporadic occurrence of clonal transmission.It is necessary to strengthen the surveillance of this pathogen.

Fig. 3
Fig. 3 Comparative analysis of the resistance and virulence genes of A. baumannii isolates.(A) Comparison of the resistance and virulence genes between CRISPR-positive and CRISPR-negative A. bauman-

Fig. 4
Fig. 4 Phylogenetic analysis of 12 A. baumannii isolates with ≤ 10 single nucleotide variations (SNVs).Isolation time is indicated as yyyy/dd/mm.The colored tracks adjacent to the tip of the phylogenetic tree show the different resistance and virulence genes, and sequence types (STs)

Table 1
Demographics, clinical and microbiological features of A. Baumannii BSIs